Companies included in IBBQ Page 3
This is IBBQ's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 201–267 of 267.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| PACB | Pacific Biosciences of California, Inc. | 16,852 | NS | 0.037378% |
| ZVRA | Zevra Therapeutics, Inc. | 3,142 | NS | 0.037044% |
| KMDA | Kamada Ltd. | 3,210 | NS | 0.036871% |
| AQST | Aquestive Therapeutics, Inc. | 6,813 | NS | 0.03598% |
| SLDB | Solid Biosciences Inc. | 4,366 | NS | 0.035796% |
| Galapagos N.V. | Galapagos N.V. | 803 | NS | 0.035685% |
| IVVD | Invivyd, Inc. | 15,472 | NS | 0.034522% |
| Prothena Corp. PLC | Prothena Corp. PLC | 2,992 | NS | 0.034248% |
| SIGA | SIGA Technologies, Inc. | 3,989 | NS | 0.034074% |
| ETON | Eton Pharmaceuticals, Inc. | 1,510 | NS | 0.033871% |
| RGNX | REGENXBIO Inc. | 2,835 | NS | 0.033836% |
| FULC | Fulcrum Therapeutics, Inc. | 3,042 | NS | 0.033656% |
| TRDA | Entrada Therapeutics, Inc. | 2,126 | NS | 0.033486% |
| LRMR | Larimar Therapeutics, Inc. | 4,770 | NS | 0.033441% |
| ALT | Altimmune, Inc. | 5,817 | NS | 0.033101% |
| TECX | Tectonic Therapeutic, Inc. | 1,045 | NS | 0.032353% |
| KROS | Keros Therapeutics, Inc. | 1,724 | NS | 0.032298% |
| PEPG | PepGen Inc. | 3,853 | NS | 0.031641% |
| LENZ | LENZ Therapeutics, Inc. | 1,768 | NS | 0.031489% |
| UPB | Upstream Bio, Inc. | 3,038 | NS | 0.030804% |
| ABSI | AbSci Corp. | 8,394 | NS | 0.030365% |
| ENTA | Enanta Pharmaceuticals, Inc. | 1,604 | NS | 0.030283% |
| AVXL | Anavex Life Sciences Corp. | 4,989 | NS | 0.029179% |
| AURA | Aura Biosciences, Inc. | 3,566 | NS | 0.02773% |
| AVIR | Atea Pharmaceuticals, Inc. | 4,376 | NS | 0.027039% |
| KYTX | Kyverna Therapeutics, Inc. | 2,433 | NS | 0.026372% |
| NGNE | Neurogene Inc. | 848 | NS | 0.026299% |
| CTNM | Contineum Therapeutics, Inc. | 1,293 | NS | 0.026187% |
| AUTL | Autolus Therapeutics PLC | 11,218 | NS | 0.025326% |
| NBP | NovaBridge Biosciences | 5,799 | NS | 0.025112% |
| IMRX | Immuneering Corp. | 3,615 | NS | 0.023816% |
| FHTX | Foghorn Therapeutics Inc. | 3,158 | NS | 0.023682% |
| CABA | Cabaletta Bio, Inc. | 5,395 | NS | 0.023648% |
| ACRS | Aclaris Therapeutics, Inc. | 6,047 | NS | 0.022913% |
| AC Immune S.A. | AC Immune S.A. | 5,590 | NS | 0.021624% |
| CADL | Candel Therapeutics, Inc. | 3,078 | NS | 0.021335% |
| PBYI | Puma Biotechnology, Inc. | 2,824 | NS | 0.021252% |
| EOLS | Evolus, Inc. | 3,626 | NS | 0.020585% |
| AARD | Aardvark Therapeutics, Inc. | 1,232 | NS | 0.020316% |
| LFCR | Lifecore Biomedical, Inc. | 2,092 | NS | 0.019886% |
| BCYC | Bicycle Therapeutics PLC | 2,589 | NS | 0.019586% |
| VOR | Vor BioPharma Inc. | 960 | NS | 0.019569% |
| CCCC | C4 Therapeutics, Inc. | 5,430 | NS | 0.019356% |
| Silence Therapeutics PLC | Silence Therapeutics PLC | 2,621 | NS | 0.018825% |
| OmniAb, Inc. | OmniAb, Inc. | 8,054 | NS | 0.018289% |
| OBIO | Orchestra Biomed Holdings, Inc. | 3,155 | NS | 0.018245% |
| ARCT | Arcturus Therapeutics Holdings Inc. | 1,610 | NS | 0.017494% |
| VYGR | Voyager Therapeutics, Inc. | 3,162 | NS | 0.017116% |
| Humacyte, Inc. | Humacyte, Inc. | 10,465 | NS | 0.015405% |
| EDIT | Editas Medicine, Inc. | 5,197 | NS | 0.015095% |
| CHRS | Coherus Oncology, Inc. | 6,762 | NS | 0.014909% |
| Quantum-Si Inc. | Quantum-Si Inc. | 10,933 | NS | 0.013805% |
| SGMT | Sagimet Biosciences Inc. | 1,749 | NS | 0.013185% |
| CRBU | Caribou Biosciences, Inc. | 5,225 | NS | 0.013107% |
| MENS | Jyong Biotech Ltd. | 4,238 | NS | 0.011974% |
| BDTX | Black Diamond Therapeutics, Inc. | 3,178 | NS | 0.010364% |
| TKNO | Alpha Teknova, Inc. | 2,973 | NS | 0.010127% |
| RANI | Rani Therapeutics Holdings, Inc. | 5,458 | NS | 0.009872% |
| GOSS | Gossamer Bio, Inc. | 12,911 | NS | 0.007243% |
| CDXS | Codexis, Inc. | 5,176 | NS | 0.006902% |
| TNYA | Tenaya Therapeutics, Inc. | 9,284 | NS | 0.006886% |
| PYXS | Pyxis Oncology, Inc. | 3,526 | NS | 0.006843% |
| RNAC | Cartesian Therapeutics, Inc. | 2,633 | NS | 0.000474% |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | 1,661 | NS | 0.000066% |
| OmniAb, Inc. | OmniAb, Inc. | 125 | NS | 0% |
| NOVOB CVR | Novo Nordisk A/S | 3,794 | NS | 0% |
| OmniAb, Inc. | OmniAb, Inc. | 125 | NS | 0% |
SEC N-PORT snapshot as of .